Patents Assigned to Pergamum AB
  • Patent number: 11000574
    Abstract: The present invention relates to pharmaceutical compositions enhancing the therapeutic effect of biologically active peptides, especially peptides derived from human lactoferrin. The compositions are useful for the treatment and/or prevention of wounds, scars, and post surgical adhesions.
    Type: Grant
    Filed: August 29, 2019
    Date of Patent: May 11, 2021
    Assignee: PERGAMUM AB
    Inventors: Margit Mahlapuu, Mattias Munnich, Veronika Sjostrand
  • Patent number: 10471129
    Abstract: The present invention relates to pharmaceutical compositions enhancing the therapeutic effect of biologically active peptides, especially peptides derived from human lactoferrin. The compositions are useful for the treatment and/or prevention of wounds, scars, and post surgical adhesions.
    Type: Grant
    Filed: December 21, 2017
    Date of Patent: November 12, 2019
    Assignee: PERGAMUM AB
    Inventors: Margit Mahlapuu, Mattias Munnich, Veronika Sjostrand
  • Patent number: 9878019
    Abstract: The present invention relates to pharmaceutical compositions enhancing the therapeutic effect of biologically active peptides, especially peptides derived from human lactoferrin. The compositions are useful for the treatment and/or prevention of wounds, scars, and post surgical adhesions.
    Type: Grant
    Filed: August 13, 2014
    Date of Patent: January 30, 2018
    Assignee: PERGAMUM AB
    Inventors: Margit Mahlapuu, Mattias Münnich, Veronika Sjöstrand
  • Patent number: 9132165
    Abstract: The present invention relates to new peptides and to use thereof, in particular for treatment and/or prevention of infections, inflammations, pain, wounds, scar and/or tumors.
    Type: Grant
    Filed: January 25, 2012
    Date of Patent: September 15, 2015
    Assignee: Pergamum AB
    Inventors: Margit Mahlapuu, Camilla Björn, Veronika Sjöstrand, Björn Walse, Bo Svenson
  • Patent number: 8846608
    Abstract: The present invention relates to new peptides and to use thereof, in particular for treatment and/or prevention of infections, inflammations, pain, wounds, scar and/or tumors.
    Type: Grant
    Filed: January 25, 2012
    Date of Patent: September 30, 2014
    Assignee: Pergamum AB
    Inventors: Margit Mahlapuu, Camilla Björn, Veronika Sjöstrand, Björn Walse, Bo Svenson
  • Publication number: 20140031296
    Abstract: The present invention relates to new peptides and to use thereof, in particular for treatment and/or prevention of infections, inflammations, pain, wounds, scar and/or tumours.
    Type: Application
    Filed: January 25, 2012
    Publication date: January 30, 2014
    Applicant: PERGAMUM AB
    Inventors: Margit Mahlapuu, Camilla Björn, Veronika Sjöstrand, Björn Walse, Bo Svenson
  • Patent number: 8551954
    Abstract: An antimicrobial peptide with heparin binding activity is described. It can be derived from endogenous mammalian proteins being substantially free from antimicrobial activity selected from the group consisting of laminin isoforms, complement factor C3, histidin rich glycoprotein and kininogen and having from 10 to 36 amino acids residues, wherein the antimicrobial peptide consists of at least four amino acid residues selected from the group consisting of K,R, and H. Also described are pharmaceutical compositions comprising said antimicrobial peptide and use of the antimicrobial peptide and/or antimicrobial/pharmaceutical composition.
    Type: Grant
    Filed: October 23, 2007
    Date of Patent: October 8, 2013
    Assignee: Pergamum AB
    Inventors: Artur Schmidtchen, Martin Malmsten